Compartilhar
Informação da revista
Vol. 42. Núm. S1.
Páginas 32 (outubro 2020)
Vol. 42. Núm. S1.
Páginas 32 (outubro 2020)
OP 27
Open Access
Bone marrow involvement in non-small cell lung cancer
Visitas
2383
S. Chulkova1,*, N. Tupitsyn2
1 1/FSBU “N. N. Blokhin National Medical Research Center of Oncology” of the Russian Ministry of Health, 2/Pirogov N. I. Russian National Research Medical University of the Russian Ministry of Health, Moscow, Russian Federation
2 1FSBU “N. N. Blokhin National Medical Research Center of Oncology” of the Russian Ministry of Health, Moscow, Russian Federation
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo

Objective: Purpose of the study is to evaluate the possibility of detection DOCs in BM and to identify the frequency of BM involvement in patients with NSCLC, as well as their effect on the population of bone marrow lymphocytes.

Case report: There is evidence that disseminated tumor cells (DOCs) in the bone marrow (BM) are precursors of subsequent distant metastases. There is evidence indicating an important role for bone marrow lymphocyte subpopulations in hematogenous metastasis. The detection of DOCs in non-small cell lung cancer (NSCLC) will provide important information about the features of metastasis, as well as the possibilities of identifying new targets for the treatment of NSCLC.

Methodology: 62 bone BM of NSCLC patients were studied by morphological and immunological methods. DOCs analysis was performed using flow cytometry (FACS Canto II, USA, Kaluza Analysis v2.1 software), monoclonal antibodies to CD45, cytokeratins directly labeled with various fluorochromes were used. Lymphocyte populations CD3, CD4, CD8, CD19, CD20, CD16, CD27 were studied.

Results: DOCs (EPCAM+CD45-) in the BM were found in 43.5% of patients (threshold level:1 cell per 10 million myelocaricytes). The presence of DOCs did not correlate with tumor size, lymph node status, stage of the tumor process. The highest detection rates of DOCs were observed at stages IA and IIA: 60.7% and 58.3% respectively. BM involvement in adenocarcinoma was observed in 45% cases, in squamous cell carcinoma - in 37% samples (p=0.501). It was found that DOCs are more often detected in more differentiated tumors (p=0.023). Significant correlations between the presence of DOCs in the BM and myelogram parameters have not been established. A decrease in the number of granulocyte germ cells was observed in 4% of BM involvement (p=0.036). A significant increase in the level of subpopulations of CD16+CD4-NK-cells (p=0.002), CD27+CD3+T-cells (p=0.015) with bone marrow damage was revealed.

Conclusion: The possibility of detecting DOCs in the BM of NSCLC patients has been established. BM involvement was 43.5%. DOCs are detected even in the early stages of NSCLC. Relationship between BM involvement and the degree of tumor differentiation was found. More frequent BM involvement was observed in adenocarcinoma compared with squamous cell carcinoma of the lung. The relationship between DOCs and bone marrow lymphocyte populations was revealed: subpopulations of CD16+CD4−, CD27+CD3+.

Baixar PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Opções de artigo
Ferramentas